Rhumbline Advisers Connect Biopharma Holdings LTD Transaction History
Rhumbline Advisers
- $113 Billion
- Q2 2025
A detailed history of Rhumbline Advisers transactions in Connect Biopharma Holdings LTD stock. As of the latest transaction made, Rhumbline Advisers holds 2,370 shares of CNTB stock, worth $5,379. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,370
Previous 2,370
-0.0%
Holding current value
$5,379
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding CNTB
# of Institutions
20Shares Held
2.63MCall Options Held
0Put Options Held
0-
Bml Capital Management, LLC Zionsville, IN1.82MShares$4.13 Million1.35% of portfolio
-
Choreo, LLC Minneapolis, MN161KShares$365,1680.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny144KShares$326,1990.0% of portfolio
-
Black Rock Inc. New York, NY104KShares$235,8320.0% of portfolio
-
Callan Capital, LLC La Jolla, CA80KShares$181,6000.0% of portfolio
About Connect Biopharma Holdings Ltd
- Ticker CNTB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,015,800
- Market Cap $125M
- Description
- Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for t...